PTPA and neoplasm: Since PP2A is a key regulator of inflammation and proteolytic responses, reduced PP2A could alter the inflammation and extracellular matrix responses in the lungs triggering altered lung function, pathology, and promote tumor initiation, growth and possibly metastasis.